The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
作者信息
Ley H L, Desmond F H
出版信息
Can Med Assoc J. 1968 Feb 10;98(6):318-21.
Abstract
摘要
相似文献
1
2
The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
Fed Proc. 1973 Apr;32(4):1435-7.
3
The Food and Drug Administration's requirements for approval of new dental drugs.
Symp Pharmacol Ther Toxicol Group. 1975 Apr 6:5-12.
4
Curbing counterfeit drugs.遏制假药
FDA Consum. 2006 Sep-Oct;40(5):11.
5
Drug safety: the viewpoint of the pharmaceutical manufacturing industry.药物安全性：制药行业的观点
Can Med Assoc J. 1968 Feb 10;98(6):314-7.
6
The Food and Drug Administration's Drug Safety Oversight Board: an evolving paradigm for clinical input on drug safety topics.美国食品药品监督管理局药品安全监督委员会：药物安全主题临床意见输入的不断演变模式
Clin Pharmacol Ther. 2010 Aug;88(2):269-74. doi: 10.1038/clpt.2010.82. Epub 2010 Jun 9.
7
The Food and Drug Administration's drug approval process.美国食品药品监督管理局的药品审批程序。
Conn Med. 1980 Mar;44(3):161-6.
8
World agencies try to stem flood of fake drugs.世界各机构努力阻止假药泛滥。
Nat Med. 2004 Feb;10(2):111. doi: 10.1038/nm0204-111a.
9
"Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.“黑匣子”101：美国食品药品监督管理局如何评估、沟通和管理药品的益处/风险。
J Allergy Clin Immunol. 2006 Jan;117(1):34-9. doi: 10.1016/j.jaci.2005.10.031.
10
Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.躲在行政自由裁量权背后：美国食品药品监督管理局的个人用药进口政策。
Cornell J Law Public Policy. 2000;9:493-521.
引用本文的文献
1
"Progress...is trouble and care".进步……伴随着麻烦与忧虑。
Can Med Assoc J. 1968 Mar 30;98(13):654-5.
Zotero 插件